Medtronic, Stryker, Boston Scientific, Intuitive Surgical, Abbott Labs. Switching costs + regulatory + brand moats compound in surgical instruments + implantable devices - the original 'razor-blade' healthcare model.
Industry leader
UFP Technologies, Inc. UFPT
Buffett-Fit: 64/100
Medical devices compound through surgeon training + hospital purchasing relationships + FDA-approved product cycles. Once a surgeon is trained on a specific implant or surgical robot, switching costs are real - retraining, recertification, and surgeon preference all favour the incumbent. Look for ROIC above 15% + gross margins above 60%.
Sorted by composite quality score - ROIC, margin stability, balance-sheet strength, growth quality. Click any ticker for the full Buffett verdict.
1.8B mcap
27.8B mcap
1.2B mcap
16.5B mcap
11.4B mcap
100.9B mcap
85.9B mcap
12.9B mcap
121.3B mcap
155.2B mcap
11.7B mcap
2.4B mcap
13.0B mcap
562M mcap
49.4B mcap
152.3B mcap
10.7B mcap
1.3B mcap
871M mcap
21.3B mcap
1.1B mcap
9.4B mcap
592M mcap
3.0B mcap
7.8B mcap
25.7B mcap
53.1B mcap
651M mcap
1.1B mcap
629M mcap
4.1B mcap
7.0B mcap
2.1B mcap
577M mcap
779M mcap
769M mcap
1.4B mcap
1.7B mcap
712M mcap
3.8B mcap
1.2B mcap
1.3B mcap
543M mcap
1.2B mcap
1.0B mcap
518M mcap
1.4B mcap
2.2B mcap
7.1B mcap
1.2B mcap
See all industries + sector-level statistics + framework filters.
Educational framework analysis only. Not investment advice, not a recommendation, not personalized to your situation. Always do your own research.